Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.

Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jiménez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M; HoT-PE Investigators .

Eur Heart J. 2019 May 23. pii: ehz367. doi: 10.1093/eurheartj/ehz367. [Epub ahead of print]

PMID:
31120118
2.

Obstructive sleep apnea is associated with pulmonary artery thrombus load, disease severity, and survival in acute pulmonary embolism.

Geissenberger F, Schwarz F, Probst M, Haberl S, Parkhe A, Faul C, von Lewinski D, Kroencke T, Schwaiblmair M, von Scheidt W, Berghaus TM.

Clin Res Cardiol. 2019 Apr 23. doi: 10.1007/s00392-019-01479-x. [Epub ahead of print]

PMID:
31016383
3.

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Kahn N, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Oqueka T, Frankenberger M, Behr J.

Respir Res. 2019 Mar 15;20(1):59. doi: 10.1186/s12931-019-1020-3.

4.

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells.

Karschnia P, Jordan JT, Forst DA, Arrillaga-Romany IC, Batchelor TT, Baehring JM, Clement NF, Gonzalez Castro LN, Herlopian A, Maus MV, Schwaiblmair MH, Soumerai JD, Takvorian RW, Hochberg EP, Barnes JA, Abramson JS, Frigault MJ, Dietrich J.

Blood. 2019 May 16;133(20):2212-2221. doi: 10.1182/blood-2018-12-893396. Epub 2019 Feb 26.

PMID:
30808634
5.

Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018.

Leuchte HH, Ten Freyhaus H, Gall H, Halank M, Hoeper MM, Kaemmerer H, Kähler C, Riemekasten G, Ulrich S, Schwaiblmair M, Ewert R.

Int J Cardiol. 2018 Dec 1;272S:20-29. doi: 10.1016/j.ijcard.2018.08.084. Epub 2018 Sep 13. Review.

PMID:
30266353
6.

Successful long-term treatment of persistent pulmonary air leak in pneumocystis jirovecii pneumonia by unidirectional endobronchial valves.

Bader S, Faul C, Raab S, Schwaiblmair M, Berghaus TM.

Respir Med Case Rep. 2018 Aug 27;25:170-173. doi: 10.1016/j.rmcr.2018.08.021. eCollection 2018.

7.

Is acute pulmonary embolism more severe in the presence of obstructive sleep apnea? Results from an observational cohort study.

Konnerth D, Schwarz F, Probst M, Seidler M, Wagner T, Faul C, von Scheidt W, Schwaiblmair M, Berghaus TM.

J Thromb Thrombolysis. 2018 Aug;46(2):253-259. doi: 10.1007/s11239-018-1665-7.

PMID:
29675617
8.

The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study.

Kutsch J, Faul C, von Scheidt W, Schwaiblmair M, Berghaus TM.

Respir Res. 2018 Jan 15;19(1):8. doi: 10.1186/s12931-017-0712-9.

9.
10.

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Herth FJF, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Frankenberger M, Behr J.

Respir Res. 2017 Jul 14;18(1):139. doi: 10.1186/s12931-017-0621-y.

11.

Obstructive sleep apnea might trigger acute pulmonary embolism: results from a cohort study.

Berghaus TM, Witkowska A, Wagner T, Faul C, Schwaiblmair M, von Scheidt W.

Clin Res Cardiol. 2016 Nov;105(11):938-943. Epub 2016 Jun 16.

PMID:
27312327
12.

[Risk stratification and follow-up assessment of patients with pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016].

Leuchte HH, Ten Freyhaus H, Gall H, Halank M, Hoeper MM, Kaemmerer H, Kähler C, Riemekasten G, Ulrich S, Schwaiblmair M, Ewert R.

Dtsch Med Wochenschr. 2016 Oct;141(S 01):S19-S25. Epub 2016 Oct 19. Review. German.

PMID:
27760446
13.

Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.

Barco S, Lankeit M, Binder H, Schellong S, Christ M, Beyer-Westendorf J, Duerschmied D, Bauersachs R, Empen K, Held M, Schwaiblmair M, Fonseca C, Jiménez D, Becattini C, Quitzau K, Konstantinides S.

Thromb Haemost. 2016 Jul 4;116(1):191-7. doi: 10.1160/TH16-01-0004. Epub 2016 Mar 24. Erratum in: Thromb Haemost. 2016 Sep 27;116(4):775.

PMID:
27010343
14.

The prevalence of sleep-disordered breathing among survivors of acute pulmonary embolism.

Berghaus TM, Faul C, von Scheidt W, Schwaiblmair M.

Sleep Breath. 2016 Mar;20(1):213-8. doi: 10.1007/s11325-015-1209-8. Epub 2015 Jun 27.

PMID:
26115650
15.

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.

Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Gläser S, Herth FJ, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhäufl M, Höffken G, Held M, Koch A, Bahmer T, Pittrow D.

Eur Respir J. 2015 Jul;46(1):186-96. doi: 10.1183/09031936.00217614. Epub 2015 Apr 2.

16.

Drug induced interstitial lung disease.

Schwaiblmair M, Behr W, Haeckel T, Märkl B, Foerg W, Berghaus T.

Open Respir Med J. 2012;6:63-74. doi: 10.2174/1874306401206010063. Epub 2012 Jul 27.

17.

Renal biomarkers and prognosis in acute pulmonary embolism.

Berghaus TM, Schwaiblmair M, von Scheidt W.

Heart. 2012 Aug;98(16):1185-6. doi: 10.1136/heartjnl-2012-302298. No abstract available.

PMID:
22826556
18.

Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension.

Schwaiblmair M, Faul C, von Scheidt W, Berghaus TM.

BMC Pulm Med. 2012 Jun 7;12:23. doi: 10.1186/1471-2466-12-23.

19.

Detection of exercise-induced pulmonary arterial hypertension by cardiopulmonary exercise testing.

Schwaiblmair M, Faul C, von Scheidt W, Berghaus TM.

Clin Cardiol. 2012 Sep;35(9):548-53. doi: 10.1002/clc.22009. Epub 2012 May 15.

20.
21.

Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011.

Grünig E, Barner A, Bell M, Claussen M, Dandel M, Dumitrescu D, Gorenflo M, Holt S, Kovacs G, Ley S, Meyer JF, Pabst S, Riemekasten G, Saur J, Schwaiblmair M, Seck C, Sinn L, Sorichter S, Winkler J, Leuchte HH.

Int J Cardiol. 2011 Dec;154 Suppl 1:S3-12. doi: 10.1016/S0167-5273(11)70488-0.

PMID:
22221971
22.

Acute pulmonary embolism in patients with obstructive sleep apnoea: does it affect the severity of sleep-disordered breathing?

Berghaus TM, Faul C, Unterer F, Thilo C, von Scheidt W, Schwaiblmair M.

Sleep Breath. 2012 Dec;16(4):1267-9. doi: 10.1007/s11325-011-0633-7. Epub 2011 Dec 21.

PMID:
22187134
23.

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.

Schwaiblmair M, Behr W, Foerg W, Berghaus T.

Expert Opin Drug Metab Toxicol. 2011 Dec;7(12):1547-60. doi: 10.1517/17425255.2011.629185. Epub 2011 Nov 9. Review.

PMID:
22070131
24.

The N-terminal pro-brain-type natriuretic peptide based short-term prognosis in patients with acute pulmonary embolism according to renal function.

Berghaus TM, Behr W, von Scheidt W, Schwaiblmair M.

J Thromb Thrombolysis. 2012 Jan;33(1):58-63. doi: 10.1007/s11239-011-0649-7.

PMID:
22033585
25.

Echocardiographic evaluation for pulmonary hypertension after recurrent pulmonary embolism.

Berghaus TM, Barac M, von Scheidt W, Schwaiblmair M.

Thromb Res. 2011 Dec;128(6):e144-7. doi: 10.1016/j.thromres.2011.07.045. Epub 2011 Aug 17.

PMID:
21851970
26.

The impact of age on the delay in diagnosis in patients with acute pulmonary embolism.

Berghaus TM, Thilo C, von Scheidt W, Schwaiblmair M.

Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):605-10. doi: 10.1177/1076029611404218. Epub 2011 May 17.

PMID:
21593023
27.

[Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with commentary of the Cologne Consensus Conference 2010].

Grünig E, Barner A, Bell M, Claussen M, Dandel M, Dumitrescu D, Gorenflo M, Holt S, Kovacs G, Ley S, Meyer JF, Pabst S, Riemekasten G, Saur J, Schwaiblmair M, Seck C, Sinn L, Sorichter S, Winkler J, Leuchte HH.

Dtsch Med Wochenschr. 2010 Oct;135 Suppl 3:S67-77. doi: 10.1055/s-0030-1263314. Epub 2010 Sep 22. German.

PMID:
20862623
28.

Time between first symptoms and diagnosis in patients with acute pulmonary embolism: are patients with recurrent episodes diagnosed earlier?

Berghaus TM, von Scheidt W, Schwaiblmair M.

Clin Res Cardiol. 2011 Feb;100(2):117-9. doi: 10.1007/s00392-010-0217-8. Epub 2010 Sep 6.

PMID:
20821017
29.

Effectiveness of thrombolysis in patients with intermediate-risk pulmonary embolism: influence on length of hospital stay.

Berghaus TM, Thilo C, Bluethgen A, von Scheidt W, Schwaiblmair M.

Adv Ther. 2010 Sep;27(9):648-54. doi: 10.1007/s12325-010-0058-x. Epub 2010 Aug 4.

PMID:
20694805
30.

Central thromboembolism is a possible predictor of right heart dysfunction in normotensive patients with acute pulmonary embolism.

Berghaus TM, Haeckel T, Behr W, Wehler M, von Scheidt W, Schwaiblmair M.

Thromb Res. 2010 Sep;126(3):e201-5. doi: 10.1016/j.thromres.2010.06.009. Epub 2010 Jul 17.

PMID:
20638710
31.

Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?

Schwaiblmair M, Berghaus T, Haeckel T, Wagner T, von Scheidt W.

Clin Res Cardiol. 2010 Nov;99(11):693-700. doi: 10.1007/s00392-010-0181-3. Epub 2010 Jul 10. Review.

PMID:
20623129
32.

A 59-year-old woman with chronic cough and multiple pulmonary nodules.

Schwaiblmair M, Haeckel T, Wagner T, Probst A, Berghaus T.

Chest. 2010 Mar;137(3):720-3. doi: 10.1378/chest.09-1669. No abstract available.

PMID:
20202955
33.

[Lipoid pneumonia - an underestimated syndrome].

Schwaiblmair M, Berghaus T, Haeckel T, Wagner T, Scheidt Wv.

Dtsch Med Wochenschr. 2010 Jan;135(1-2):27-31. doi: 10.1055/s-0029-1244813. Epub 2009 Dec 18. Review. German.

PMID:
20024881
34.

Endogenous lipoid pneumonia associated with primary sclerosing cholangitis.

Berghaus TM, Haeckel T, Wagner T, von Scheidt W, Schwaiblmair MG.

Lancet. 2007 Mar 31;369(9567):1140. No abstract available.

PMID:
17398313
35.

Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome?

Neurohr C, Huppmann P, Leuchte H, Schwaiblmair M, Bittmann I, Jaeger G, Hatz R, Frey L, Uberfuhr P, Reichart B, Behr J; Munich Lung Transplant Group.

Am J Transplant. 2005 Dec;5(12):2982-91.

36.

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

Leuchte HH, Holzapfel M, Baumgartner RA, Ding I, Neurohr C, Vogeser M, Kolbe T, Schwaiblmair M, Behr J.

J Am Coll Cardiol. 2004 Mar 3;43(5):764-70.

37.

Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.

Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J.

Chest. 2004 Feb;125(2):580-6.

PMID:
14769741
38.

Administration of anti-interleukin-2Ralpha monoclonal antibody in bronchiolitis obliterans syndrome after lung transplantation.

Ding IB, Baumgartner RA, Schwaiblmair M, Behr J.

Transplantation. 2003 May 27;75(10):1767-9. No abstract available.

PMID:
12777880
39.

Bronchial epithelial cell B7-1 and B7-2 mRNA expression after lung transplantation: a role in allograft rejection?

Elssner A, Jaumann F, Wolf WP, Schwaiblmair M, Behr J, Fürst H, Reichenspurner H, Briegel J, Niedermeyer J, Vogelmeier C.

Eur Respir J. 2002 Jul;20(1):165-9.

40.

Myosplint implant and shape-change procedure: intra- and peri-operative safety and feasibility.

Schenk S, Reichenspurner H, Boehm DH, Groetzner J, Schirmer J, Detter C, Koglin J, Schwaiblmair M, Meiser B, Reichart B.

J Heart Lung Transplant. 2002 Jun;21(6):680-6.

PMID:
12057702
41.

Pulmonary diffusing capacity: assessment with oxygen-enhanced lung MR imaging preliminary findings.

Müller CJ, Schwaiblmair M, Scheidler J, Deimling M, Weber J, Löffler RB, Reiser MF.

Radiology. 2002 Feb;222(2):499-506.

PMID:
11818619
42.

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W.

J Am Coll Cardiol. 2001 Dec;38(7):1934-41.

43.

Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy.

Boekstegers P, Steinbigler P, Molnar A, Schwaiblmair M, Becker A, Knez A, Haberl R, Steinbeck G.

J Am Coll Cardiol. 2001 Sep;38(3):846-53.

44.

Cellular chimerism of the lung after transplantation. An interphase cytogenetic study.

Bittmann I, Dose T, Baretton GB, Müller C, Schwaiblmair M, Kur F, Löhrs U.

Am J Clin Pathol. 2001 Apr;115(4):525-33.

PMID:
11293900
45.

Clinical value of brain natriuretic peptide for candidate selection before cardiac transplantation.

Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, Von Scheidt W.

J Heart Lung Transplant. 2001 Feb;20(2):164. No abstract available.

PMID:
11250248
46.
47.

Optimization and evaluation of the signal intensity change in multisection oxygen-enhanced MR lung imaging.

Löffler R, Müller CJ, Peller M, Penzkofer H, Deimling M, Schwaiblmair M, Scheidler J, Reiser M.

Magn Reson Med. 2000 Jun;43(6):860-6.

48.

Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung transplantation. The Munich Lung Transplant Group.

Behr J, Maier K, Braun B, Schwaiblmair M, Vogelmeier C.

Transplantation. 2000 May 15;69(9):1856-60.

PMID:
10830222
49.

Incomplete sympathic reinnervation of the orthotopically transplanted human heart: observation up to 13 years after heart transplantation.

Uberfuhr P, Ziegler S, Schwaiblmair M, Reichart B, Schwaiger M.

Eur J Cardiothorac Surg. 2000 Feb;17(2):161-8.

PMID:
10731652
50.

Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity.

Hirsch J, Elssner A, Mazur G, Maier KL, Bittmann I, Behr J, Schwaiblmair M, Reichenspurner H, Fürst H, Briegel J, Vogelmeier C.

Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1640-6.

PMID:
10556134

Supplemental Content

Loading ...
Support Center